.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have achieved a breakthrough in liver-targeted mRNA delivery by developing a novel immune-modulating nanodrug. This innovation addresses a significant hurdle in genetic medicine. Currently, inflammation often hampers the success of mRNA-based therapies. Specifically, inflammatory states trigger a self-defensive response in hepatocytes. This mechanism downregulates global protein synthesis to block potential viral threats. However, it also significantly reduces the efficiency of therapeutic mRNA delivered via lipid nanoparticles (LNPs).
Furthermore, the team introduced a telodendrimer (TD) nanodrug (ND) to modulate the immune environment. They tested this technology in both human and mouse immune cells. Additionally, the researchers evaluated its effects on primary human hepatocytes (PHH). The results were impressive. The TD ND successfully inhibited endotoxin-induced inflammation. Consequently, this led to improved cell proliferation and significantly higher mRNA uptake in human monocytes and liver cells.
Moreover, the findings demonstrated that TD ND is superior to conventional steroid drugs. While steroids are common, they can sometimes impair liver recovery. In contrast, the TD ND sustained liver function in mice while rebooting the efficacy of liver-targeted mRNA delivery. Therefore, this adjuvant therapy offers a promising path for treating inflammatory liver diseases.
Inflammation acts as a biological barrier. It triggers a cellular defense that reduces mRNA expression, which prevents therapeutic genes from being translated into functional proteins.
The TD nanodrug acts as an immune modulator. It inhibits the inflammatory response that normally blocks mRNA expression, thereby enhancing the overall delivery efficiency and liver function.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new telodendrimer nanodrug improves liver-targeted mRNA delivery by suppressing inflammation and outperforming traditional steroids in preclinical studies...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
